References
- Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005;5:172–183.
- Nowell P, Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497.
- Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukaemia in mice by the P210BCR-ABL gene of the Philadelphia chromosome. Science. 1990;247:824–830.
- Elefanty AG, Hariharan IK, Cory S. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J. 1990;9:1069–1078.
- Heisterkamp N, Jenster G, ten Hoeve J, et al. Acute leukaemia in bcr/abl transgenic mice. Nature. 1990;344:251–253.
- Kelliher MA, McLaughlin J, Witte ON, et al. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA. 1990;87:6649–6653.
- Buyse 1M, Shao G, Huang S. The retinoblastoma protein binds to RIZ. A zincfinger protein that shares an epitope with the adenovirus EIA protein. Proc Natl Acad Sci USA. 1995;92:4467–4471.
- Liu L, Shao G, Steele-Perkins G, et al. The relinoblastoma interacting/ine finger gene ff/X produces a PR domain lacking product through an internal promoter. J Biol Chem. 1999;272:2984–2991.
- Nagai H, Negrini M, Carter SL, et al. Detection and cloning of a common region of loss of heterozygosity at chromosome Ip in breast cancer. Cancer Res. 1995;55:1752–1757.
- Genuardi M, Tsihira H, Anderson DE, et al. Distal deletion of chromosome Ip in ductal carcinoma of the breast. Am J Hum Genet. 1989;5:73–82.
- Simon D, Knowles BB, Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on Ip in primary hepalomas. Oncogene. 1991;6:765–770.
- Sasaki O, Meguro K, Tohmiya Y, et al. Altered expression or retinoblastoma protein-interacting zinc finger, RIZ, in human leukemia. Br J Haematol. 2002;119:940–949.
- Pastural E, Takahashi N, Dong W-F, et al. RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines. Oncogene. 2007;26:1586–1594.
- Fang W, Piao Z, Simon D, et al. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer. 2000;28:269–275.
- Cline MJ. The molecular basis of leukemia. N Engl J Med. 1994;330:328–336.
- Hassan R, Ramli M, Zaidah W, et al. One-step multiplex RT-PCR for detection of BCR/ABL gene in Malay patients with chronic myeloid leukaemia. Asia Pacif J Mol Biol Biotechnol. 2008;16:41–44.
- Hollingsworth RE Jr, Chen PL, Lee WH. Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein. Curr Opin Cell Biol. 1993;5:194–200.
- Buyse IM, Shao G, Huang S, et al. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA. 1995;92:4467–4447.
- Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248–5257.
- Koo SH, Jeong TE, Kang JU, et al. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. Cancer Genet Cytogenet. 2004;153:26–23.
- Tanaka K, Mansoor AM, Shigeta C, et al. Loss of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. Cancer Genet Cytogenet. 1992;61:42–45.
- Fang W, Piao Z, Buyse IM, et al. Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma. Br J Cancer. 2007;84:743–747.
- Abbondanza C, Medici N, Nigro V, et al. The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci USA. 2000;97:3130–3135.
- Mori N, Morosetti R, Lee S, et al. Allelotype analysis in the evolution of chronic myeloid leukemia. Blood. 1997;90:210–214.
- He L, Yu JX, Liu L, et al. RIZ1, but not the alternative RIZ2 product of the same gene, is under expressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res. 1998;58:4238–4244.
- Canzian F, Salovaara R, Hemminki A, et al. A semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res. 1996;56:3331–3337.
- Imtiyaz A, Rashid M, Mariyam Z, et al. Inactivation of RIZ1 gene by promoter hypermethylation is associated with disease progression and resistance to Imatinib in Indian Chronic myelogenous leukemia patients. J Cancer Sci Ther. 2013;5:045–051.
- Chadwick RB, Jiang G-L, Bennington GA, Bo Y, et al. Candidate tumour suppressor RIZ is frequently involved in colorectal carcinogenesis. PNAS. 2000;6:2662–2667. [https://doi.org/WorldCat]
- Khaenam P, Jearanaikoon P, Pairojkul C, et al. Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma. Exp Ther Med. 2010;1:385–390.
- Stolk L, van Meurs JB, Arp PP, et al. The RIZ Pro704 insertion–deletion polymorphism, bone mineral density and fracture risk: The Rotterdam study. Bone. 2008;42:286–293.